Index removal puts National Health Investors in focus

National Health Investors (NHI) has been removed from several Russell growth benchmarks, including the Russell 2000 and Russell 3000 indexes, drawing attention to how index tracking flows might influence the stock.

Following the index removals, National Health Investors' share price has held around $77.49, with a 10.02% 1 month share price return contrasting with a 6.65% decline over three months. Its 1 year total shareholder return of 14.70% and 3 year total shareholder return of 73.60% point to stronger longer term performance.

If this index reshuffle has you thinking about where else capital might move, it could be a useful time to scan 20 top founder-led companies

With National Health Investors trading near $77.49, a value score of 4, an indicated intrinsic discount of about 53% and only a small gap to analyst targets, investors have to ask whether there is genuine upside left here or whether the market is already pricing in future growth.

Most Popular Narrative: 9.6% Undervalued

Against a last close of $77.49, the most followed narrative for National Health Investors points to a fair value of $85.75, framing the stock as modestly undervalued based on long term cash flow potential and sector demand for senior housing.

Accelerating growth in the 75+ U.S. population and increased demand for senior housing are driving higher occupancy rates and pricing power in NHI's SHOP portfolio, evidenced by recent quarter over quarter rises in both occupancy and RevPOR, this should support sustained revenue and net operating income (NOI) growth.

To see what sits behind that fair value for National Health Investors, the narrative focuses on steady revenue expansion, firm margins, and the potential for a richer future earnings multiple.

Result: Fair Value of $85.75 (UNDERVALUED)

However, the National Health Investors story could look very different if SHOP occupancy softness persists or if key tenants underperform and put pressure on rental income.

Next Steps

If this mix of optimism and concern around National Health Investors leaves you undecided, review the data while it is current and form your own view with 2 key rewards and 3 important warning signs

Looking for more investment ideas beyond National Health Investors?

If National Health Investors has sharpened your thinking, do not stop here. Broaden your watchlist with fresh ideas that match different goals and risk levels.

• Target dependable income by reviewing 7 dividend fortresses that focus on higher yielding payouts for investors who want cash flow to play a bigger role in returns.
• Hunt for value by scanning screener containing 18 high quality undiscovered gems that may not be on everyone's radar but still show solid fundamentals and room for a stronger market profile.
• Prioritise resilience by checking 74 resilient stocks with low risk scores that aim to limit downside, so you are not scrambling for options only after volatility hits.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.